Form 4 for SVRA Savara Inc
Accepted 2022-11-22 00:00:00 ET · period of report 2022-11-21 · accession 0001209191-22-058356 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-11-22 | 2022-11-21 | SVRA | Pratt Raymond Dennis | Chief Medical Off | A - Grant | $0.00 | +150.0K | 150.0K | New | $0 |
| D | 2022-11-22 | 2022-11-21 | SVRA | Pratt Raymond Dennis | Chief Medical Off | A - Grant | $0.00 | +375.0K | 375.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-21 | A | A | 150,000 | $0.00 | 150,000 | D | — | — | (F1) Represents restricted stock units ("RSUs") that vest in full on November 10, 2024, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock. |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-11-21 | A | A | 375,000 | $0.00 | 375,000 | D | $1.43 · — to 2032-11-21 | 375,000 Common Stock | (F2) The option vests and becomes exercisable in sixteen equal installments on each quarterly anniversary of November 10, 2022, subject to the reporting person's continued service with the Issuer. |